foscarbidopa 120 MG / foslevodopa 2400 MG per 10 ML Injection
- RxCUI
- 2695782
- RxNorm name
- foscarbidopa 120 MG / foslevodopa 2400 MG per 10 ML Injection
- Display name
- foscarbidopa 120 MG / foslevodopa 2400 MG per 10 ML Injection
- Full name
- foscarbidopa 120 MG / foslevodopa 2400 MG per 10 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vyalev | FOSCARBIDOPA/FOSLEVODOPA | AbbVie Inc. | 28e806e4-951c-40a9-9f0c-d0929caf054c | 2026-03-19 | Warnings, Adverse reactions | 2695782 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 28e806e4-951c-40a9-9f0c-d0929caf054c | foscarbidopa 120 MG / foslevodopa 2400 MG per 10 ML Injection | SY | 6 | These highlights do not include all the information needed to use VYALEV safely and effectively. See full prescribing information for VYALEV. VYALEV™ (foscarbidopa and foslevodopa) injection, for subcutaneous use Initial U.S. Approval: 1975 | 20260319 |
| 28e806e4-951c-40a9-9f0c-d0929caf054c | 10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use VYALEV safely and effectively. See full prescribing information for VYALEV. VYALEV™ (foscarbidopa and foslevodopa) injection, for subcutaneous use Initial U.S. Approval: 1975 | 20260319 |
| 28e806e4-951c-40a9-9f0c-d0929caf054c | foscarbidopa 120 MG / foslevodopa 2400 MG in 10 ML Injection | PSN | 6 | These highlights do not include all the information needed to use VYALEV safely and effectively. See full prescribing information for VYALEV. VYALEV™ (foscarbidopa and foslevodopa) injection, for subcutaneous use Initial U.S. Approval: 1975 | 20260319 |